KLB and hepatocellular carcinoma: Given that disruption of the regulatory system controlling G1 phase progression is a common event in human hepatocarcinogenesis and cyclin D1 overexpression plays a carcinogenic role in HCC[29], our data suggested βKlotho inhibited hepatoma cells growth by down-regulation of cyclin D1.